LAUREN ISLEY: Open Payments
NPI 1992194146 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 34 payments from 8 companies in 2025. Trend: 2023 $240 · 2024 $273 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $205 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $146 |
| Axsome Therapeutics, Inc. | 4 | $65 |
| Vanda Pharmaceuticals Inc. | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
Products named: VRAYLAR, TRINTELLIX, HETLIOZ, REXULTI, Sunosi, Quviviq, CAPLYTA, Jornay PM.
Industry payments across SC — which companies pay providers there.
